DELFI Diagnostics Alternatives & Competitors
12 companies similar to DELFI Diagnostics — DELFI's AI and whole-genome sequencing platform detects cancer-associated cfDNA...
Companies similar to DELFI Diagnostics
Nucleix Ltd.
Developing cancer diagnostic panels based on epigenetic bio markers
Rehovot, Israel
Cyted Health
Transforming access to digestive health for everyone, everywhere.
Cambridge, United Kingdom
Neogene Therapeutics
Pushing the frontier by pioneering next-generation engineered T cell receptor therapies fo...
Amsterdam, The Netherland...
CellMax Life
Liquid biopsy company focused on cancer screening with a proprietary platform for detectin...
Sunnyvale, United States
Rival Readout
Competing with DELFI Diagnostics? We do this properly.
10 rivals, 90 days of dated moves, ranked by what matters and sourced, in 7 business days.
Valladolid, Spain
Oxford Cancer Analytics
Enabling curative cancer treatment through early detection
Oxford, United Kingdom
Apostle Inc
Apostle is a provider of innovative technologies and services for public health and life s...
Pleasanton, United States
Lucence
Overcoming cancer through earlier detection
Palo Alto, United States
Mainz Biomed
Saving lives through innovative molecular diagnostic solutions.
Mainz, Germany
Entia
Unlocking the full potential of cancer therapy with at-home blood monitoring
London, United Kingdom
RhoDx, Inc.
Reducing Cancer Morbidity and Mortality through Early Detection and Monitoring.
United States
Massive Bio
AI-driven system connecting cancer patients to clinical trials in real time. Industrializi...
Istanbul, Turkey
About DELFI Diagnostics
DELFI Diagnostics, founded in 2019, is at the forefront of the convergence of AI and biotechnology, focusing on health care through early cancer detection. Their slogan, "Saving lives through early cancer detection," encapsulates their mission of leveraging artificial intelligence and whole genome sequencing to identif...
Cancer Detection Solutions, Liquid Biopsy Diagnostics, Clinical Trial Services, Research and Innovation in Fragmentomics, Machine Learning Application in Genomic Sequencing
Healthcare Providers, Patients, Pharmaceutical Companies, Biotech Researchers, Hospital Systems
Cancer Detection, Early Detection, Genome Sequencing, DNA Fragmentation, Medical Technology, Healthcare Innovation
Frequently Asked Questions
From the desk
Mapping a market? Start with a Rival Readout.
In 7 business days we read 10 rivals around DELFI Diagnostics: 90 days of dated moves, ranked by what matters to you, each with its source. Fully credited if you continue.
Compiled from the BounceWatch company index. We last looked at DELFI Diagnostics on 9 Jun 2026. The 12 companies listed here were last checked between 11 Sep 2024 and 2 Sep 2026. Where a field is blank here, it means we have not recorded it — not that the answer is zero. How we source and date this.
